Drug intelligence / Profile preview

hyoscine butyl bromide + lidocaine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Subcutaneous, Rectal
01

Overview

Hyoscine butyl bromide + lidocaine is a combination drug consisting of two active pharmaceutical ingredients: - **Hyoscine butyl bromide** (also known as scopolamine butylbromide or HBB) is an anticholinergic agent that acts primarily as a peripherally selective muscarinic receptor antagonist. It relaxes smooth muscle in the gastrointestinal and genitourinary tracts by blocking acetylcholine at muscarinic receptors, leading to spasmolytic and analgesic effects. It does not cross the blood-brain barrier due to its quaternary ammonium structure[1][2][6]. - **Lidocaine** is a local anesthetic of the amide type that works by blocking voltage-gated sodium channels on neuronal cell membranes, thereby inhibiting nerve impulse conduction and providing local anesthesia. The combination may be used for conditions where both smooth muscle relaxation (antispasmodic effect) and local anesthesia are desired—such as certain diagnostic procedures or pain management scenarios involving abdominal or pelvic organs. The specific indications for this exact combination are not widely documented in major formularies; however, both agents are well-established individually for their respective uses.

Other names
hyoscine N-butylbromide + lidocainescopolamine butylbromide + lidocaineHBB + lidocaine
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)CHRM2 (M2)CHRM3 (M3)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on hyoscine butyl bromide + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyoscine butyl bromide + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call